Letter: non-invasive prediction models to exclude cirrhosis in NAFLD - not everyone fits the mould

Related Experiment Video

Updated: Sep 20, 2025

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.1K

Suprabhat Giri1, Dhiraj Agrawal2, Shivaraj Afzalpurkar3

  • 1Department of Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, India.

Alimentary Pharmacology & Therapeutics
|June 10, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.4K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.1K

Related Experiment Videos

Last Updated: Sep 20, 2025

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
07:13

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH

Published on: April 20, 2021

4.1K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.4K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

12.1K

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

211
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
211

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness of tofacitinib as rescue therapy in biological-naive patients with steroid-refractory acute severe ulcerative colitis: a multicentric retrospective analysis.

European journal of gastroenterology & hepatology·2026

Immune-checkpoint inhibitors for advanced hepatocellular carcinoma in Child-Turcotte-Pugh-B cirrhosis: a liver-centric approach to outcomes beyond tumor progression.

Hepatology international·2026

Donor steatosis in the metabolic dysfunction-associated steatotic liver disease era: a retrospective analysis of challenges and outcomes in living donor liver transplantation.

Clinical transplantation and research·2026

Comprehensive review on the current management of lower-gut bleed.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026

Melioidosis presenting as hepatosplenic abscesses: A case series.

Tropical doctor·2025

Incidence, Predictors, Management, and Outcome of Paralytic Ileus in Acute Pancreatitis.

Pancreas·2025

Maternal Obesity Is Associated With Adverse Pregnancy Outcomes in Inflammatory Bowel Disease: A Matched Electronic Health Record Cohort Study.

Alimentary pharmacology & therapeutics·2026

Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.

Alimentary pharmacology & therapeutics·2026

Management and Outcomes of Bleeding Ectopic Varices in Patients With Liver Cirrhosis: A Systematic Review and Pooled Analysis.

Alimentary pharmacology & therapeutics·2026

Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients.

Alimentary pharmacology & therapeutics·2026

Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease.

Alimentary pharmacology & therapeutics·2026

Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non-Anticoagulated Patients.

Alimentary pharmacology & therapeutics·2026

Transcriptomic identification of high-altitude illness candidate genes and physiological mechanisms: a multidimensional bioinformatics study with 106 drug-food homologous substance target prediction.

Frontiers in physiology·2026

Updated Management of Sodium Disorders During Continuous Venovenous Hemofiltration.

Seminars in dialysis·2026

Comparison of cardiac magnetic resonance findings in idiopathipulmonary arterial hypertension and that associated with CHD.

Cardiology in the young·2026

Stroke-Heart Syndrome: Mechanisms, Temporal Phenotypes, and Diagnostic Reasoning.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Immediate drug hypersensitivity severity is associated with cardiovascular risk.

Allergy and asthma proceedings·2026

CLAG3 mutations reduce hemoglobin S-mediated protection against malaria.

Trends in parasitology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us